规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
---|---|---|---|---|---|---|---|---|---|
5g | ¥ ưưůǤǤ | > 10 | 6 | -- | -- | -- | -- | ¥ ưưůǤǤ | - + |
10g | ¥ ǵNJʼnůǤǤ | 3 | -- | -- | -- | -- | ¥ ǵNJʼnůǤǤ | - + | |
25g | ¥ NJʼnźůǤǤ | 3 | 1 | -- | -- | -- | -- | ¥ NJʼnźůǤǤ | - + |
100g | ¥ ǵNJǵȎůǤǤ | -- | -- | -- | -- | -- | -- | ¥ ǵNJǵȎůǤǤ | - + |
500g | ¥ ưȎŢĽůǤǤ | -- | -- | -- | -- | -- | -- | ¥ ưȎŢĽůǤǤ | - + |
1000g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
210.6
[1]. Arts IC, et al. Adenosine 5'-triphosphate (ATP) supplements are not orally bioavailable: a randomized, placebo-controlled cross-over trial in healthy humans. J Int Soc Sports Nutr. 2012 Apr 17;9(1):16.
[2]. Hechler B, et al. The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation. Blood. 199 Jul 1;92(1):152-9.
[3]. David Erlinge, et al. P2Y receptors in health and disease. Adv Pharmacol. 2011:61:17-39.
[]. David Iyú, et al. Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist. Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):16-22.
[5]. Lizhen Qiao, et al. A novel surface-confined glucaminium-based ionic liquid stationary phase for hydrophilic interaction/anion-exchange mixed-mode chromatography. J Chromatogr A. 20 Sep 19:1360:20-7.
P261-P26-P270-P271-P20-P302+P352-P30+P30-P305+P351+P33-P330-P362+P36-P03+P233-P05-P501